Page last updated: 2024-10-17

aminocaproic acid and Carcinoma, Anaplastic

aminocaproic acid has been researched along with Carcinoma, Anaplastic in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BONMASSAR, E1
PRADA, A1
ROBOTTI, CA1

Other Studies

1 other study available for aminocaproic acid and Carcinoma, Anaplastic

ArticleYear
[THE ACETYL DERIVATIVE EPSILON-AMINOCAPROIC ACID AS AN AGENT FAVORING THE INDUCTION AND DEVELOPMENT OF EHRLICH'S CARCINOMA IN THE RAT].
    Bollettino della Societa italiana di biologia sperimentale, 1963, Oct-31, Volume: 39

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Pharmacology; Rats;

1963